Andreas Broedel

Andreas Broedel is a skilled leader in drug discovery and synthetic biology, currently serving as Team Leader at Eligo Bioscience since 2019, where Andreas manages a team of 5 to 7 scientists and contributes to preclinical R&D across various therapeutic areas, holding co-inventorship on four biomedical patents and a first-author publication in Nature. Prior experience includes roles as Senior Scientist and Research Scientist at Imperial College London from 2014 to 2019, where Andreas managed interdisciplinary projects, published in prestigious journals, supported substantial grant acquisition, and supervised numerous students. As a Doctoral Researcher at Fraunhofer IBMT from 2010 to 2014, Andreas published several peer-reviewed articles and presented research at international conferences. Educational credentials include a Doctor of Natural Sciences from the University of Potsdam and a Diplom-Ingenieur in Chemical and Bioengineering from FAU Erlangen-Nürnberg.